|
|
Legal status
Patent lapsed (non-payment of fees)
| (51) | INT.CL. | A01N 37/18 | (2006.01) |
| A61K 38/28 | (2006.01) | ||
| A61K 38/00 | (2006.01) | ||
| A61K 38/54 | (2006.01) |
| (11) | Number of the document | 1771201 |
| (13) | Kind of document | T |
| (96) | European patent application number | 05786347.4 |
| Date of filing the European patent application | 2005-06-15 | |
| (97) | Date of publication of the European application | 2007-04-11 |
| (45) | Date of publication and mention of the grant of the patent | 2014-08-13 |
| (46) | Date of publication of the claims translation | 2014-12-29 |
| (86) | Number | PCT/US2005/021134 |
| Date | 2005-06-15 |
| (87) | Number | WO 2005/123116 |
| Date | 2005-12-29 |
| (30) | Number | Date | Country code |
| 868242 | 2004-06-15 | US |
| (72) |
SIDHU, Harmeet, US
|
| (73) |
OxThera Intellectual Property AB,
Sturegatan 56, 114 36 Stockholm,
SE
|
| (74) |
Otilija KLIMAITIENĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Kompozicijos ir būdai skirti su oksalatu susijusių ligų gydymui ir prevencijai |
| COMPOSITIONS AND METHODS FOR TREATING OR PREVENTING OXALATE-RELATED DISEASE |
| Payment date | Validity (years) | Amount | |
| 2022-05-19 | 18 | 347.00 EUR |
| Patent lapsed (non-payment of fees) | ||
| Invalidation date | 2023-06-15 |